ArticlePloS one2015

FMS-like tyrosine kinase 3 ligand treatment does not ameliorate experimental rapidly progressive glomerulonephritis.

Joanna R Ghali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.